| Dr Robert G Credi, MD | |
|
621 Memorial Dr Ste 502, South Bend, IN 46601-1075 | |
| (574) 647-5875 | |
| (574) 647-5878 |
| Full Name | Dr Robert G Credi |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 36 Years |
| Location | 621 Memorial Dr Ste 502, South Bend, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013907781 | NPI | - | NPPES |
| 200078980 | Medicaid | IN | |
| 236040415 | Other | IN | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 01044047A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hospital Of South Bend | South bend, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beacon Medical Group Inc | 1254243306 | 452 |
News Archive
A simple saliva test to detect if someone has recently taken the street drug "spice" has been developed at the University of Bath – the first such test ever created.
Residents of states with limited access to contraceptives and high rates of unplanned pregnancies are more likely to turn to the internet for information about abortion. These are the findings of a new study of Google search data across all 50 states by researchers at the University of California, Berkeley.
Boehringer Ingelheim Ltd. today announces that Health Canada has granted approval of PRADAX (dabigatran etexilate), an oral anticoagulant for the prevention of stroke and systemic embolism in adults with atrial fibrillation in whom anticoagulation is appropriate. PRADAX is the first innovative drug approved in Canada in more than two decades to reduce the risk of stroke in Canadians with atrial fibrillation.
A startling indicates that obesity may reduce the immune response to the current COVID-19 vaccines, along with other factors like age and sex. This could have significant implications for vaccination strategies in obese people.
› Verified 7 days ago
| Entity Name | Beacon Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033161617 PECOS PAC ID: 1254243306 Enrollment ID: O20031105000657 |
News Archive
A simple saliva test to detect if someone has recently taken the street drug "spice" has been developed at the University of Bath – the first such test ever created.
Residents of states with limited access to contraceptives and high rates of unplanned pregnancies are more likely to turn to the internet for information about abortion. These are the findings of a new study of Google search data across all 50 states by researchers at the University of California, Berkeley.
Boehringer Ingelheim Ltd. today announces that Health Canada has granted approval of PRADAX (dabigatran etexilate), an oral anticoagulant for the prevention of stroke and systemic embolism in adults with atrial fibrillation in whom anticoagulation is appropriate. PRADAX is the first innovative drug approved in Canada in more than two decades to reduce the risk of stroke in Canadians with atrial fibrillation.
A startling indicates that obesity may reduce the immune response to the current COVID-19 vaccines, along with other factors like age and sex. This could have significant implications for vaccination strategies in obese people.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert G Credi, MD 710 N Niles Ave, South Bend, IN 46617-1924 Ph: (574) 647-1610 | Dr Robert G Credi, MD 621 Memorial Dr Ste 502, South Bend, IN 46601-1075 Ph: (574) 647-5875 |
News Archive
A simple saliva test to detect if someone has recently taken the street drug "spice" has been developed at the University of Bath – the first such test ever created.
Residents of states with limited access to contraceptives and high rates of unplanned pregnancies are more likely to turn to the internet for information about abortion. These are the findings of a new study of Google search data across all 50 states by researchers at the University of California, Berkeley.
Boehringer Ingelheim Ltd. today announces that Health Canada has granted approval of PRADAX (dabigatran etexilate), an oral anticoagulant for the prevention of stroke and systemic embolism in adults with atrial fibrillation in whom anticoagulation is appropriate. PRADAX is the first innovative drug approved in Canada in more than two decades to reduce the risk of stroke in Canadians with atrial fibrillation.
A startling indicates that obesity may reduce the immune response to the current COVID-19 vaccines, along with other factors like age and sex. This could have significant implications for vaccination strategies in obese people.
› Verified 7 days ago
Marie E Unruh, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 Navarre Pl Ste 5500, South Bend, IN 46601 Phone: 574-647-5200 Fax: 574-647-5210 | |
Scott G Thomas, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 621 Memorial Dr, Suite 502, South Bend, IN 46601 Phone: 574-647-5875 Fax: 574-647-5878 | |
Michael C Rotkis, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 621 Memorial Dr, South Bend, IN 46601 Phone: 574-236-1888 Fax: 574-236-1887 | |
William Anderson, MD Surgery Medicare: Medicare Enrolled Practice Location: 621 Memorial Dr, Ste 502, South Bend, IN 46601 Phone: 574-647-5875 Fax: 515-643-5802 | |
George B Friend, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 621 Memorial Dr, South Bend, IN 46601 Phone: 574-236-1888 Fax: 574-236-1888 | |
Daniel P. Srikureja, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 621 Memorial Dr Ste 502, South Bend, IN 46601 Phone: 574-647-5875 Fax: 574-647-5878 |